Table 3.

Comparison of MetS and its components between PCOS subgroups and control group

	H + P + O group${}^{\mathrm{A}}$ (n = 41)	H + P group${}^{\mathrm{B}}$ (n = 33)	O + P group${}^{\mathrm{C}}$ (n = 40)	H + O group${}^{\mathrm{D}}$ (n = 37)	Control (n = 31)	P-value*	pair wise comparison; MW, P-value
MetS (+) n (%)	7 (17.1)	1 (3)	1 (2.5)	5 (13.5)	0 (0.0)	0.01	-
FBS, median (IQR)	91.0 (7.5)	88.0 (10.5)	87.0 (10.7)	90.0 (16.5)	79.0 (17.0)	<0.001	A & Control, p $<$ 0.001 B & Control, p = 0.001 C & Control, p = 0.005 D & Control, p = 0.004
HDL-C, median (IQR)	45.0 (16.5)	52.0 (15.0)	51.5 (13.2)	49.0 (13.0)	56.0 (10.0)	<0.001	A & Control, p $<$ 0.001 C & Control, p = 0.002 D & Control, p $<$ 0.001
TG, median (IQR)	126.0 (93.5)	94.0 (86.5)	90.5 (77.0)	99.0 (91.5)	85.0 (70.0)	0.40	-
WC, median (IQR)	85.0 (14.5)	81.0 (11.0)	82.0 (11.5)	84.0 (12.7)	81.0 (15.0)	0.65	-
SBP, median (IQR)	110.0 (16.0)	110.0 (13.0)	114.5 (10.0)	118.0 (16.0)	110.0 (13.0)	<0.001	A & D, p = 0.003 D & Control, p = 0.004
DBP, median (IQR)	68.0 (27.5)	70.0 (15.0)	74.5 (20.0)	79.0 (10.0)	70.0 (12.0)	0.01	A & D, p = 0.003 B & D, p = 0.003
MetS: Metabolic syndrome; FBS: Fasting blood sugar; HDL-C: High-density lipoprotein cholesterol; TG: Triglyceride; WC: Waist circumference; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; MW: Mann-Whitney's U test *P-values refer to the Kruskal-Wallis test followed by appropriate post hoc test (Mann-Whitney U test) (p $<$ 0.005 was considered significant for multiple comparisons based on Bonferroni correction); p-value for the variable MetS refers to the Fisher's exact test (p $<$ 0.05 was considered significant) Significant results are shown in the table exclusively